Dr. Anderson has been a central figure in the discovery that DNA damage is heritable, and you’ll build on this work by using molecular methods to unravel the forces that modulate mutagenesis across the genome of mutagen-exposed cells. You’ll be introduced to advanced statistical and computational methods for analyzing the data you create. Your findings will be a vital part of understanding the evolution of cancer drug resistance in cell models and in patients.
The German Cancer Research Center (DKFZ) is one of Europe's largest cancer research centers. «Research for a life without cancer" is the mission of our world-class scientists and all our team members.
The DKFZ is a place where the brightest minds pursue bold ideas and seek answers to pioneering scientific questions through collaboration, innovation, and exploration across many disciplines. We provide a dynamic environment which empowers excellence with state-of-the-art technologies, cutting edge infrastructure, and a global scientific network.
Contribute your knowledge, vision, and dedication to create a space where scientific discovery in cancer research is transformed into benefits for human health.
Together with selected university partner sites, the DKFZ has established the
German Cancer Consortium (DKTK)
. The alliance between the DKFZ as the core center and the university partner sites in Berlin, Dresden, Essen/Düsseldorf, Frankfurt/Mainz, Freiburg, Heidelberg, Munich, and Tübingen operates joint translation centers at the University Medical Centers of each of the selected partner sites. The DKTK contributes significantly to filling the translational gap between basic and clinical cancer research, thereby developing new strategies for personalized oncology in prevention, diagnosis, and treatment of cancer. DKTK conducts transformative translational cancer research, educates the next generation of translation-oriented medical and clinical scientists and establishes strong pipelines towards clinical cancer research and the economy.
We are seeking for the Cancer Systems Biology lab of Dr. Craig Anderson at the DKTK partner site Munich a
From cigarette smoke and UV radiation, to chemotherapeutic cancer treatments, the cells in our bodies are continuously under siege from exogenous agents that damage our DNA. The molecular mechanisms that repair and tolerate this damage are also responsible for the mutations that drive disease progression and therapy resistance. How and when these mutational processes act remains poorly understood. This is where you come in.
The Cancer Systems Biology lab of Dr. Craig Anderson is searching for an enthusiastic PhD student, starting in September 2026, to play a principal role in understanding how DNA damage leads to mutational heterogeneity across our bodies and over the course of our lives.
The lab is situated in the Department of Translational Oncology at the LMU Klinikum, Munich.
Munich itself is a beautiful and centrally located city, offering all the trappings of a modern lifestyle. It provides easy access to other cities and green spaces across the region, regularly scoring highly across indices for happiness and quality of life.
We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.
Notice: We are subject to the regulations of the Infection Protection Act (IfSG). Therefore, all our employees must provide proof of immunity against measles.
Dr. Craig Anderson
Phone: +49 (0)89 4400-43962
Deutsches Krebsforschungszentrum | Im Neuenheimer Feld 280 | 69120 Heidelberg | www.dkfz.de